- Grants since 2016
- 489
- Awarded, last 5 years (where amounts are published)
- €181.1M
- Funded works, last 5 years
- 3 159
- Funded works, all time
- 5 628
Grants
2020–2023 · research · RIA
Host immune responses to SARS-CoV-2: correlating kinetics with the natural history of infection
Francis Ndungu · Health Research Operations Kenya Limited
2020–2024 · fellowship · TMA
Alternative treatment strategies using anti-wolbachial drugs to accelerate elimination of onchocerciasis and lymphatic filariasis
Alexander Yaw Debrah · Kwame Nkrumah University of Science and Technology
2020–2025 · research · RIA
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
Alberto García-Basteiro · Fundación Privada Instituto De Salud Global Barcelona (isglobal)
2020–2024 · research · CSA
Capacity development to facilitate the delivery and uptake of Fexinidazole for the elimination of Human African Trypanosomiasis.
Florent Mbo · Drugs for Neglected Diseases Initiative
2020–2024 · fellowship · TMA
Metabolic and molecular ecological evolution of opportunistic pulmonary fungal co-infections
Herbert Itabangi · Mbarara University of Science and Technology
2020–2022 · research · RIA
Covid-19 epidemic in West Africa: infection dynamics and diagnostic approaches
Annette Erhart · London School of Hygiene & Tropical Medicine
2020–2022 · research · RIA
Natural History and Laboratory Tests for COVID-19 in South Africa
Ayesha Kharsany · Centre for the AIDS Programme of Research in South Africa
2020–2024 · research · RIA
Preventing and delaying the development of diabetes in Africa: a randomised placebo-controlled double-blind phase III trial of metformin in HIV-infected persons with pre-diabetes
Shabbar Jaffar · University College London
2020–2021 · research · RIA
Transmission of Covid-19 in crowded Environments
Linda-Gail Bekker · Desmond Tutu HIV Foundation
2020–2021 · fellowship · TMA
TMA2018 IF [ DIALLO]
Nouhoum Diallo · Université des Sciences, des Techniques et des Technologies de Bamako
2020–2025 · research · RIA
Randomised Controlled Trial of Preventive Treatment of Latent Tuberculosis Infection in Patients with Diabetes Mellitus
Reinout Van Crevel · Stichting Katholieke Universiteit- Radboudumc (rumc)
2020–2023 · fellowship · TMA
The influence of tuberculosis treatment on the emergence of antimicrobial resistance amongst the ESKAPE bacteria
Suventha Moodley · Stellenbosch University
2020–2025 · fellowship · TMA
Clinical application of whole genome sequencing in multidrug resistance tuberculosis patients in Tanzania
Bugwesa Zablon Katale · Tanzania Commission for Science and Technology
2020–2025 · fellowship · TMA
Using SMS reminders, phone calls and MM incentives to enhance linkage to care of presumptive tuberculosis patients in Uganda: a randomised controlled trial.
Esther Buregyeya · Makerere University
2020–2025 · research · RIA
Towards a pediatric indication for children between 1 and 14 years of age for a safe, effective, all-oral single-dose treatment formulation of acoziborole for first and second stage gambiense human African trypanosomiasis (g-HAT)
Sandra Rembry · Drugs for Neglected Diseases Initiative
2020–2024 · fellowship · TMA
Impact of Seasonal Malaria Chemoprevention on the buildup of protective immunity and the protection against clinical malaria in Burkina Faso
Mariama Cherif · Groupe De Recherche Action En Santé (gras)
2020–2022 · fellowship · TMA
Patho-immunological modulatory effect of the human gut microbiome in children with severe P. falciparum infections from Cross River, southern Nigeria
Mary Oboh · Medical Research Council (mrc) Unit - The Gambia
2020–2024 · fellowship · TMA
Pharmacomicrobiomics in Malaria-HIV co-infection (MHC) treatment outcome: Finding causal therapeutic variation in Artemisinin-based combination therapy (ACT) and antiretroviral therapy (ART) in a Ghanaian population
Nicholas Ekow Thomford · University of Cape Coast
2020–2024 · fellowship · TMA
Mobile nucleic acid testing of asymptomatic Plasmodium infections for malaria elimination
Makhtar Niang · Institut Pasteur de Dakar
2020–2025 · research · RIA
Early Risk Assessment in TB Contacts by new diagnoStic tEsts
Norbert Heinrich · Ludwig-maximilians-universitaet Muenchen (lmu)
2020–2022 · research · RIA
Determining the epidemiological parameters of COVID-19 through sero-surveillance with Dried Plasma Spots and nested household transmission studies in rural Kenya and South Africa
Till Winfried Baernighausen · Heidelberg University
2020–2025 · research · RIA
Community and Universal Testing for TB among contacts
Salome Charalambous · Aurum Institute
2020–2026 · fellowship · TMA
Adaptation of blood-stage CHMI for evaluation of transmission blocking malaria interventions in endemic countries.
Ally Olotu · Ifakara Health Institute Trust (ihi)
2020–2021 · fellowship · TMA
TMA2018PF- LoI - [Adegbola]-Developing genomics expertise at Copenhagen in order to examine to what extent dhps-431V Mutation may influence the protective efficacy of IPTp-SP
Adebanjo Adegbola · Obafemi Awolowo University
2020–2023 · fellowship · TMA
Evaluating the impact of sociodemographic and geographic access to immunization service points on TIMEliness and deLaYs of infant vaccinations in The Gambia
Oghenebrume Wariri · Medical Research Council (mrc) Unit - The Gambia
2020–2022 · research · RIA
Surveillance among healthcare workers for SARS-Coronavirus–2 infection
Marta Nunes · Wits Health Consortium (pty) Ltd
2020–2022 · research · RIA
Understanding COVID-19 infections in pregnant women and their babies in Uganda, Kenya, Malawi, the Gambia and Mozambique
Kirsty Le Doare · St George's, University of London
2020–2025 · research · RIA
BREATHER Plus: A randomised open-label 3-arm, 96-week trial evaluating the efficacy, safety and acceptability of weekends off dolutegravir-based antiretroviral therapy (ART) and monthly long-acting injectable ART compared to daily dolutegravir-based ART in virologically suppressed HIV-infected children and adolescents in sub-Saharan Africa
Adeodata (Addy) Kekitiinwa - Rukyalekere · Baylor College Of Medicine Children's Foundation - Uganda
2020–2025 · research · RIA
VITamin D for AdoLescents with HIV to reduce musculoskeletal morbidity and ImmunopaThologY (VITALITY): an individually randomised, double-blinded placebo-controlled trial
Rashida Ferrand · London School of Hygiene & Tropical Medicine
2020–2025 · fellowship · TMA
Career Strengthening for Improved Randomised Controlled Trials in Uganda
Victoria Nankabirwa · Makerere University
2020–2025 · research · RIA
A randomized control trial to evaluate a scalable active case-finding intervention for tuberculosis using a point-of-care molecular tool (Xpert Omni)
Keertan Dheda · The University Of Cape Town Lung Institute (pty) Ltd
2020–2025 · research · RIA
A randomized control trial to evaluate a scalable active case-finding intervention for tuberculosis using a point-of-care molecular tool (Xpert Omni)
Keertan Dheda · The University Of Cape Town Lung Institute (pty) Ltd
2020–2025 · research · RIA
Determination of Adequate TUberculosis Regimen in Adults and adolescents hospitalised with HIV-associated severe immune suppression (CD4 ≤ 100 cells/µL)
Laureillard Didier · L'institut National De La Santé Et De La Recherche Médicale (inserm)
2020–2025 · fellowship · TMA
Strengthening vaccine research at CERMEL focusing on biomedical and social sciences
Selidji Todagbe Agnandji · Centre de Recherche Médicales de Lambaréné
2020–2023 · research · RIA
Characterising transmission parameters of SARS-CoV-2 in a peri-urban setting in Mozambique using population-based surveillance and a high-throughput sero-assay.
Brecht Ingelbeen · Prins Leopold Instituut Voor Tropische Geneeskunde (itm)
2020–2025 · fellowship · TMA
Innate Immunological Mechanisms of Control and Factors Driving Inflammation in HIV Controllers from a high incidence setting in South Africa-Prospects for HIV Cure
Christina Thobakgale · University of the Witwatersrand
2019–2023 · fellowship · TMA
Evaluation of Pharmacokinetics and Safety/Tolerability of Higher Doses of Rifampicin in Children with Newly Diagnosed, Uncomplicated Tuberculosis
Hadija Hamisi Semvua · Kilimanjaro Clinical Research Institute (kcri)/ Kilimanjaro Christian Medical Centre (kcmc)
2019–2024 · fellowship · TMA
Determining Correlates of Naturally Acquired Pre-Erythrocytic Immunity to Plasmodium falciparum Malaria in an Experimental Human Challenge Model
Francis Ndungu · Health Research Operations Kenya Limited
2019–2025 · research · RIA
A phase 2 and 3 clinical trial program to assess safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa
Abdoulaye Djimde · Université des Sciences, des Techniques et des Technologies de Bamako
2019–2022 · fellowship · TMA
Neutrophils as effector cells in resistance to infection by Mycobacterium tuberculosis in HIV-infected persons
Elouise Kroon · Stellenbosch University